Free Trial

Enovix (NASDAQ:ENVX) Trading Up 11.9%

Enovix logo with Oils/Energy background

Enovix Co. (NASDAQ:ENVX - Get Free Report)'s share price was up 11.9% during mid-day trading on Monday . The company traded as high as $9.56 and last traded at $9.52. Approximately 1,380,162 shares traded hands during trading, a decline of 71% from the average daily volume of 4,818,477 shares. The stock had previously closed at $8.51.

Analyst Ratings Changes

A number of research analysts have issued reports on ENVX shares. B. Riley reduced their target price on shares of Enovix from $18.00 to $16.00 and set a "buy" rating for the company in a research note on Tuesday, April 30th. Cantor Fitzgerald reissued an "overweight" rating and set a $30.00 target price on shares of Enovix in a research note on Thursday, April 25th. Craig Hallum reduced their target price on shares of Enovix from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Thursday, May 2nd. JPMorgan Chase & Co. reduced their price target on shares of Enovix from $18.00 to $12.00 and set an "overweight" rating for the company in a research note on Friday, April 26th. Finally, William Blair reaffirmed an "outperform" rating on shares of Enovix in a research note on Thursday, May 2nd. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, Enovix presently has an average rating of "Moderate Buy" and an average price target of $18.33.

Read Our Latest Stock Report on ENVX

Enovix Trading Up 3.2 %

The company has a debt-to-equity ratio of 0.72, a quick ratio of 4.77 and a current ratio of 4.89. The business's 50 day moving average price is $7.80 and its two-hundred day moving average price is $9.97. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of -6.55 and a beta of 1.70.


Enovix (NASDAQ:ENVX - Get Free Report) last released its earnings results on Tuesday, February 20th. The company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.34) by ($0.01). Enovix had a negative return on equity of 85.47% and a negative net margin of 1,448.90%. The business had revenue of $7.38 million during the quarter, compared to the consensus estimate of $3.37 million. Equities analysts forecast that Enovix Co. will post -1.15 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Ajay Marathe sold 4,954 shares of the business's stock in a transaction that occurred on Sunday, April 14th. The shares were sold at an average price of $7.31, for a total value of $36,213.74. Following the sale, the chief operating officer now directly owns 978,913 shares in the company, valued at approximately $7,155,854.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 17.30% of the company's stock.

Institutional Investors Weigh In On Enovix

A number of large investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Enovix by 1.3% during the first quarter. Vanguard Group Inc. now owns 13,093,710 shares of the company's stock valued at $104,881,000 after acquiring an additional 164,717 shares during the period. Electron Capital Partners LLC raised its holdings in shares of Enovix by 20.0% during the fourth quarter. Electron Capital Partners LLC now owns 3,239,296 shares of the company's stock valued at $40,556,000 after acquiring an additional 540,399 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Enovix by 2,228.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,438,011 shares of the company's stock valued at $11,518,000 after acquiring an additional 1,376,253 shares during the period. Masters Capital Management LLC raised its holdings in shares of Enovix by 18.2% during the fourth quarter. Masters Capital Management LLC now owns 1,300,000 shares of the company's stock valued at $16,276,000 after acquiring an additional 200,000 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Enovix by 5.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,089,959 shares of the company's stock valued at $13,646,000 after acquiring an additional 55,157 shares during the period. Institutional investors and hedge funds own 50.92% of the company's stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Should you invest $1,000 in Enovix right now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy or Bail? Stock Upgrades and Downgrades
Profit Like Congress: The Stocks They’re Betting On
Cathie Wood’s AMD Buy: Smart Move or Risky Business

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines